Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease (Q71015295)
Jump to navigation
Jump to search
scientific article published on 01 February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease |
scientific article published on 01 February 1996 |
Statements
Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease (English)
Zietman AL
Dallow KC
McManus PA
Heney NM
1 February 1996